Abstract
A lot of experimental data has been produced which suggests that there is a crucial role for glycans during the different stages of melanoma progression. Malignant transformation is associated with various alterations in the glycosylation pattern of the protein glycans. The most common changes are associated with the presence of more branched and hypersialylated N-linked oligosaccharides, re-expression of fetal-type antigens and premature terminated glycans. Some of these changes may provide the tumor cells with an advantage in influencing their social behavior and facilitating metastasis formation so, glycan-target therapy in combination with existing protocols may have an important impact in the treatment of melanoma.
Keywords: Glycan markers, glycosyltransferases, melanoma, transformation
Current Cancer Therapy Reviews
Title: Protein Glycosylation as Marker of Melanoma Progression
Volume: 4 Issue: 2
Author(s): Anna Litynska, Malgorzata Przybylo, Dorota Hoja-Lukowicz, Ewa Pochec, Marcelina Kremser, Dorota Ciolczyk-Wierzbicka, Maria Labedz and Piotr Laidler
Affiliation:
Keywords: Glycan markers, glycosyltransferases, melanoma, transformation
Abstract: A lot of experimental data has been produced which suggests that there is a crucial role for glycans during the different stages of melanoma progression. Malignant transformation is associated with various alterations in the glycosylation pattern of the protein glycans. The most common changes are associated with the presence of more branched and hypersialylated N-linked oligosaccharides, re-expression of fetal-type antigens and premature terminated glycans. Some of these changes may provide the tumor cells with an advantage in influencing their social behavior and facilitating metastasis formation so, glycan-target therapy in combination with existing protocols may have an important impact in the treatment of melanoma.
Export Options
About this article
Cite this article as:
Litynska Anna, Przybylo Malgorzata, Hoja-Lukowicz Dorota, Pochec Ewa, Kremser Marcelina, Ciolczyk-Wierzbicka Dorota, Labedz Maria and Laidler Piotr, Protein Glycosylation as Marker of Melanoma Progression, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310115
DOI https://dx.doi.org/10.2174/157339408784310115 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Generation of Fusion Proteins for Selective Occlusion of Tumor Vessels
Current Drug Discovery Technologies Opioid Free Anaesthesia and Cancer
Current Pharmaceutical Design Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives
Current Topics in Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery A Mechanistic Study on Altered Pharmacokinetics of Irinotecan by St. Johns Wort
Current Drug Metabolism Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review
Current Medicinal Chemistry Illuminating microRNA Transcription from the Epigenome
Current Genomics Anticancer Effect of a Curcumin Derivative B63: ROS Production and Mitochondrial Dysfunction
Current Cancer Drug Targets Lectins in Human Cancer: Both a Devil and an Angel?
Current Protein & Peptide Science Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?
Current Cancer Drug Targets The Challenge of Exploiting ABCG2 in the Clinic
Current Pharmaceutical Biotechnology The Possible Use of Terpene Compounds in DC Immunotherapy against Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Targeting Microglial Polarization to Improve TBI Outcomes
CNS & Neurological Disorders - Drug Targets Mining the Adenovirus "Virome" for Systemic Oncolytics
Current Pharmaceutical Biotechnology Cisplatin Is a DNA-Damaging Antitumour Compound Triggering Multifactorial Biochemical Responses in Cancer Cells: Importance of Apoptotic Pathways
Current Medicinal Chemistry - Anti-Cancer Agents Immune Therapy in Pancreatic Cancer: Now and the Future?
Reviews on Recent Clinical Trials Obesity-Driven Inflammation and Colorectal Cancer
Current Medicinal Chemistry The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum- Induced Peripheral Neurotoxicity
Current Cancer Drug Targets What is the Current Role of Immunotherapy for Colon Cancer?
Reviews on Recent Clinical Trials